Cargando…

Combination of Immune-Related Network and Molecular Typing Analysis Defines a Three-Gene Signature for Predicting Prognosis of Triple-Negative Breast Cancer

Recent breakthroughs in immune checkpoint inhibitors (ICIs) have shown promise in triple-negative breast cancer (TNBC). Due to the intrinsic heterogeneity among TNBC, clinical response to ICIs varies greatly among individuals. Thus, discovering rational biomarkers to select susceptible patients for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Jinguo, Pan, Shuaikang, Han, Chaoqiang, Jin, Hongwei, Sun, Qingqing, Du, Jun, Han, Xinghua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687467/ https://www.ncbi.nlm.nih.gov/pubmed/36358906 http://dx.doi.org/10.3390/biom12111556

Ejemplares similares

Immune checkpoints expression patterns in early-stage triple-negative breast cancer predict prognosis and remodel the tumor immune microenvironment
por: Zhang, Jinguo, et al.
Publicado: (2023)

Systematic Investigation of the Multifaceted Role of SOX11 in Cancer
por: Sun, Qingqing, et al.
Publicado: (2022)

Immunostimulatory Properties of Chemotherapy in Breast Cancer: From Immunogenic Modulation Mechanisms to Clinical Practice
por: Zhang, Jinguo, et al.
Publicado: (2022)

Dissecting the Role of N6-Methylandenosine-Related Long Non-coding RNAs Signature in Prognosis and Immune Microenvironment of Breast Cancer
por: Zhang, Jinguo, et al.
Publicado: (2021)

Corrigendum: Dissecting the Role of N6-Methylandenosine-Related Long Non-Coding RNAs Signature in Prognosis and Immune Microenvironment of Breast Cancer
por: Zhang, Jinguo, et al.
Publicado: (2021)

Ki67 as a predictor of poor prognosis in patients with triple-negative breast cancer
por: LI, HAITAO, et al.
Publicado: (2015)

Transcriptome-Based Network Analysis Unveils Eight Immune-Related Genes as Molecular Signatures in the Immunomodulatory Subtype of Triple-Negative Breast Cancer
por: Zhang, Jinguo, et al.
Publicado: (2020)

Identification of a Hypoxia-Related Molecular Classification and Hypoxic Tumor Microenvironment Signature for Predicting the Prognosis of Patients with Triple-Negative Breast Cancer
por: Sun, Xiaoli, et al.
Publicado: (2021)

The 3′UTR signature defines a highly metastatic subgroup of triple-negative breast cancer
por: Wang, Lei, et al.
Publicado: (2016)

An EMT-Related Gene Signature to Predict the Prognosis of Triple-Negative Breast Cancer
por: Zhang, Bo, et al.
Publicado: (2023)

Identification of immune-related signature for the prognosis and benefit of immunotherapy in triple-negative breast cancer
por: Sun, Xiaorui, et al.
Publicado: (2022)

Cytotoxic Lymphocyte-Related Gene Signature in Triple-Negative Breast Cancer
por: Han, Yiqun, et al.
Publicado: (2023)

Three-microRNA expression signature predicts survival in triple-negative breast cancer
por: Wu, Xinquan, et al.
Publicado: (2020)

Identification of a prognosis-associated signature associated with energy metabolism in triple-negative breast cancer
por: Li, Chao, et al.
Publicado: (2020)

A Novel Platelet-Related Gene Signature for Predicting the Prognosis of Triple-Negative Breast Cancer
por: Xie, Jindong, et al.
Publicado: (2022)

Identification of a novel glycolysis-related prognosis risk signature in triple-negative breast cancer
por: Ruan, Yuxia, et al.
Publicado: (2023)

A novel defined cuproptosis-related gene signature for predicting the prognosis of lung adenocarcinoma
por: Zhang, Huizhe, et al.
Publicado: (2022)

A three-long noncoding RNA signature as a diagnostic biomarker for differentiating between triple-negative and non-triple-negative breast cancers
por: Liu, Man, et al.
Publicado: (2017)

Comparison of Clinicopathological Features and Prognosis in Triple-Negative and Non-Triple Negative Breast Cancer
por: Qiu, Jingdan, et al.
Publicado: (2016)

Development and validation of an inflammatory response-related signature in triple negative breast cancer for predicting prognosis and immunotherapy
por: Guo, Yangyang, et al.
Publicado: (2023)

A newly defined risk signature, consisting of three m(6)A RNA methylation regulators, predicts the prognosis of ovarian cancer
por: Fan, Lili, et al.
Publicado: (2020)

A prognostic signature based on three-genes expression in triple-negative breast tumours with residual disease
por: Pinto, Joseph A, et al.
Publicado: (2016)

Metabolomics-Based Discovery of Molecular Signatures for Triple Negative Breast Cancer in Asian Female Population
por: Li, Lixian, et al.
Publicado: (2020)

Defining triple‐negative breast cancer with neuroendocrine differentiation (TNBC‐NED)
por: Hacking, Sean M, et al.
Publicado: (2023)

Clinical features and prognosis of triple-negative breast cancer
por: Sanz, M Izquierdo, et al.
Publicado: (2009)

T-cadherin is associated with prognosis in triple-negative breast cancer
por: Kong, De-Di, et al.
Publicado: (2017)

Development and validation of a novel 15‐CpG‐based signature for predicting prognosis in triple‐negative breast cancer
por: Peng, Yang, et al.
Publicado: (2020)

A 16-gene signature associated with homologous recombination deficiency for prognosis prediction in patients with triple-negative breast cancer
por: Wang, Daodu, et al.
Publicado: (2022)

Establishment of a novel cytokine-related 8-gene signature for distinguishing and predicting the prognosis of triple-negative breast cancer
por: Liu, Xiaojun, et al.
Publicado: (2023)

A novel defined hypoxia-related gene signature to predict the prognosis of oral squamous cell carcinoma
por: Han, Ying, et al.
Publicado: (2021)

Distinct microbiological signatures associated with triple negative breast cancer
por: Banerjee, Sagarika, et al.
Publicado: (2015)

Identification of immunosuppressive signature subtypes and prognostic risk signatures in triple-negative breast cancer
por: Ding, Ran, et al.
Publicado: (2023)

Molecular classification of triple-negative tumors
por: Prat, A, et al.
Publicado: (2011)

Expression of VEGF and Semaphorin Genes Define Subgroups of Triple Negative Breast Cancer
por: Bender, R. Joseph, et al.
Publicado: (2013)

Defining super-enhancer landscape in triple-negative breast cancer by multiomic profiling
por: Huang, Hao, et al.
Publicado: (2021)

Triple-negative breast cancer: current treatment strategies and factors of negative prognosis
por: Baranova, Anna, et al.
Publicado: (2022)

Significance of combined TGF-β1 and survivin expression on the prognosis of patients with triple-negative breast cancer
por: Liu, Nannan, et al.
Publicado: (2022)

Combined mRNAs and clinical factors model on predicting prognosis in patients with triple-negative breast cancer
por: Hu, Yanjun, et al.
Publicado: (2021)

A MiRNA Signature for Defining Aggressive Phenotype and Prognosis in Gliomas
por: Barbano, Raffaela, et al.
Publicado: (2014)

Systemically Identifying Triple-Negative Breast Cancer Subtype-Specific Prognosis Signatures, Based on Single-Cell RNA-Seq Data
por: Xing, Kaiyuan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ihc2i2gj40k5d4tjq3c67vr404